Oral administration of an HSP90 inhibitor, 17-DMAG, intervenes tumor-cell infiltration into multiple organs and improves survival period for ATL model mice.
Ikebe E, Kawaguchi A, Tezuka K, Taguchi S, Hirose S, Matsumoto T, Mitsui T, Senba K, Nishizono A, Hori M, Hasegawa H, Yamada Y, Ueno T, Tanaka Y, Sawa H, Hall W, Minami Y, Jeang KT, Ogata M, Morishita K, Hasegawa H, Fujisawa J, Iha H.
Ikebe E, et al. Among authors: hasegawa h.
Blood Cancer J. 2013 Aug 16;3(8):e132. doi: 10.1038/bcj.2013.30.
Blood Cancer J. 2013.
PMID: 23955587
Free PMC article.